Better Therapeutics (NSDQ:BTTX) announced that it completed patient enrollment in a study of its digital therapeutic in treating diabetes. San Francisco–based Better Therapeutics’ BT-001 prescription digital therapeutic delivers a novel form of cognitive-behavioral therapy to patients with uncontrolled type 2 diabetes. Get the full story at our sister site, Drug Delivery Business News.
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
FDA gives Bexson pre-IND guidance for ketamine formulation delivered by wearable pump
Bexson Biomedical announced today that it received pre-investigational new drug guidance from the FDA for its ketamine compound therapy. Santa Barbara, California-based Bexson develops the patented BB106 formulation, a ketamine therapy delivered through a wearable, subcutaneous patch pump in development with Stevanato Group. Get the full story at our sister site, Drug Delivery Business News.
FDA grants breakthrough nod to Blackrock Neurotech’s brain-computer interface
Blackrock Neurotech announced that it received FDA breakthrough device designation for its MoveAgain brain-computer interface (BCI) system. Salt Lake City-based Blackrock Neurotech designed its MoveAgain BCI system to provide immobile patients the ability to control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device by only thinking, according to a news release. The company […]
Pear Therapeutics picks up another $50M ahead of going public through SPAC merger
Pear Therapeutics and Thimble Point Acquisition Corp. announced today that they received additional funding worth $50 million ahead of a merger. Boston-based Pear Therapeutics confirmed in June that it will go public by merging Thimble Point Acquisition Corp., a special purpose acquisition company (SPAC). A special meeting will be held for Thimble Point stockholders to […]
Time recognizes Abbott offerings among this year’s 100 best inventions
Abbott (NYSE:ABT) was among a series of medtech companies to receive recognition from Time in its list of 2021’s best inventions. The list of the year’s top inventions included Abbott’s innovations twice, with a nod to its NeuroSphere Virtual Clinic and its at-home COVID-19 testing offerings. Get the full story at our sister site, Medical Design & Outsourcing.
FDA clears Magstim advanced transcranial magnetic stimulation platform
Magstim announced today that it received FDA 510(k) clearance for its Horizon 3.0 transcranial magnetic stimulation platform. Horizon 3.0 offers enhanced workflows with navigated transcranial magnetic stimulation (TMS) and analytics for the clinical setting, offering connected care at networked sites, according to a news release. TMS, a form of non-invasive brain stimulation, uses an electromagnetic […]
FDA issues Class I recall for Zimmer Biomet’s Rosa One 3.1 Brain Application robotic platform
The FDA today confirmed a Class I recall for the Zimmer Biomet (NYSE:ZBH) Rosa One 3.1 Brain Application platform for robot-assisted neurosurgery procedures. Zimmer Biomet sent an urgent medical device correction on Sept. 22 for the platform as a result of a software error. Affected devices — of which there were 119 total in the […]
FDA grants breakthrough nod to Magnus Medical’s neurostim treatment for depression
Magnus Medical announced today that it received FDA breakthrough device designation for its neurostimulation technology and raised $25 million. Burlingame, California-based Magnus designed its individualized, rapid-acting, non-invasive neurostimulation platform to treat major depressive disorder (MDD) for people who have not improved sufficiently from antidepressant medication or other treatments. Magnus based its system on SAINT technology, […]
Integra Lifesciences announces new CEO
Integra LifeSciences (NSDQ:IART) announced today that former Barco CEO Jan D. De Witte will take over the corner office at Integra by the end of the year. De Witte left Barco effective September 1. He will succeed Peter J. Arduini, who is leaving Integra Lifesciences to lead GE Healthcare. The top spot at Integra will […]
Monteris Medical scores reimbursement win with Cigna
Monteris Medical announced today that Cigna released a national coverage policy supporting the use of its laser ablation therapy. The medical coverage policy considers Minnetonka, Minnesota-based Monteris’ robot-assisted, MR-guided laser interstitial thermal therapy (LITT or laser ablation) medically necessary to treat drug-resistant epilepsy and symptomatic brain tumors and radiation necrosis. According to a news release, […]
Boston Scientific reports mixed results in Q3
Boston Scientific (NYSE:BSX) shares are down today on third-quarter results that were mixed compared to the consensus forecast. The Marlborough, Massachusetts–based company posted profits of $419 million, or 28¢ per share, on sales of $2.9 billion for the three months ended Sept. 30, 2021, for a bottom-line gain from losses of $155 million this time […]